KLOW is a precision-engineered peptide formulation designed to target multiple pathways of regeneration, recovery, and systemic support. Each serving delivers GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg), and KPV (10 mg), providing a broad-spectrum research profile.
-
GHK-Cu is a naturally occurring copper-binding peptide studied for its role in collagen synthesis, wound healing, skin rejuvenation, and cellular repair.
-
BPC-157 is a stable gastric pentadecapeptide investigated for accelerating tendon, ligament, and muscle healing while supporting gastrointestinal and vascular protection.
-
TB-500, a synthetic fragment of Thymosin Beta-4, is studied for its ability to promote angiogenesis, cell migration, and tissue regeneration.
-
KPV, a tripeptide fragment of α-MSH, is investigated for its potent anti-inflammatory and antimicrobial properties, supporting immune modulation and tissue recovery.
Together, these peptides create a synergistic profile aimed at enhancing repair, reducing inflammation, and supporting regenerative research across musculoskeletal, vascular, and dermatological systems.
